Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atypical antipsychotics
Pharma
Teva bags long-sought reformulated olanzapine schizophrenia nod
With a Friday go-ahead from the FDA, another key piece of Teva’s innovation revamp strategy has fallen into place.
Fraiser Kansteiner
Oct 9, 2026 9:56am
J&J touts Caplyta win in 1 of 2 bipolar manic episode studies
Sep 21, 2026 2:30pm
FDA signs off on Vanda's Bysanti for schizophrenia and bipolar I
Feb 23, 2026 11:35am
Otsuka, Lundbeck's Rexulti snubbed by FDA in PTSD
Sep 22, 2025 4:42pm
BMS touts commercial execution, reckons with clinical setbacks
Jul 31, 2025 11:10am
FDA advisors overwhelmingly reject Lundbeck, Otsuka's PTSD drug
Jul 21, 2025 11:34am
